BACKGROUND: Understanding of the interplay between plasma HIV RNA level and CD4 cell count depletion in untreated infection remains incomplete. METHODS: We studied 1169 people with HIV seen for care at a major London clinic while naive to antiretroviral therapy. We considered pairs (n = 5940) of consecutive simultaneously measured CD4 cell count and plasma HIV RNA values from patients who had never started therapy. Baseline was the first date when both measures were known. RESULTS: HIV RNA levels increased variably and often substantially from baseline (60% experience an increase of over 50 000 copies/ml by 5 years of follow-up). The current HIV RNA level (i.e. first value of the pair) was strongly associated with the time-standardized change in CD4 cell count, with a mean 106 cells/microl per year greater rate of CD4 cell count decline per log-copy/ml higher current HIV RNA level (P < 0.0001). After adjustment for the current level, higher baseline HIV RNA was not associated with CD4 cell count decline. There was no average CD4 cell count decline with current HIV RNA level below 3.0 log-copies/ml, compared with a 159 cells/microl per year decline for those with HIV RNA at least 5.5 log-copies/ml (P < 0.0001). Further, the current CD4 cell count predicted subsequent changes in HIV RNA level (0.04 log-copies/year greater increases per 100 cells/microl lower CD4 cell count; P < 0.0001). CONCLUSION: The often substantial increases in HIV RNA level observed in untreated HIV infection appear fundamentally linked to CD4 cell count depletion. Research into mechanisms by which HIV RNA levels rise over time should yield insights into the causes of CD4 cell count depletion, as the two processes are intimately linked.
BACKGROUND: Understanding of the interplay between plasma HIV RNA level and CD4 cell count depletion in untreated infection remains incomplete. METHODS: We studied 1169 people with HIV seen for care at a major London clinic while naive to antiretroviral therapy. We considered pairs (n = 5940) of consecutive simultaneously measured CD4 cell count and plasma HIV RNA values from patients who had never started therapy. Baseline was the first date when both measures were known. RESULTS: HIV RNA levels increased variably and often substantially from baseline (60% experience an increase of over 50 000 copies/ml by 5 years of follow-up). The current HIV RNA level (i.e. first value of the pair) was strongly associated with the time-standardized change in CD4 cell count, with a mean 106 cells/microl per year greater rate of CD4 cell count decline per log-copy/ml higher current HIV RNA level (P < 0.0001). After adjustment for the current level, higher baseline HIV RNA was not associated with CD4 cell count decline. There was no average CD4 cell count decline with current HIV RNA level below 3.0 log-copies/ml, compared with a 159 cells/microl per year decline for those with HIV RNA at least 5.5 log-copies/ml (P < 0.0001). Further, the current CD4 cell count predicted subsequent changes in HIV RNA level (0.04 log-copies/year greater increases per 100 cells/microl lower CD4 cell count; P < 0.0001). CONCLUSION: The often substantial increases in HIV RNA level observed in untreated HIV infection appear fundamentally linked to CD4 cell count depletion. Research into mechanisms by which HIV RNA levels rise over time should yield insights into the causes of CD4 cell count depletion, as the two processes are intimately linked.
Authors: Cynthia L Monaco; David B Gootenberg; Guoyan Zhao; Scott A Handley; Musie S Ghebremichael; Efrem S Lim; Alex Lankowski; Megan T Baldridge; Craig B Wilen; Meaghan Flagg; Jason M Norman; Brian C Keller; Jesús Mario Luévano; David Wang; Yap Boum; Jeffrey N Martin; Peter W Hunt; David R Bangsberg; Mark J Siedner; Douglas S Kwon; Herbert W Virgin Journal: Cell Host Microbe Date: 2016-03-09 Impact factor: 21.023
Authors: Aubin J Nanfack; Andrew D Redd; Jude S Bimela; Genesis Ncham; Emmanuel Achem; Andrew N Banin; Allison R Kirkpatrick; Stephen F Porcella; Lucy A Agyingi; Josephine Meli; Vittorio Colizzi; Arthur Nádas; Miroslaw K Gorny; Phillipe N Nyambi; Thomas C Quinn; Ralf Duerr Journal: J Clin Microbiol Date: 2017-06-28 Impact factor: 5.948
Authors: Marta Catalfamo; Christopher Wilhelm; Lueng Tcheung; Michael Proschan; Travis Friesen; Jung-Hyun Park; Joseph Adelsberger; Michael Baseler; Frank Maldarelli; Richard Davey; Gregg Roby; Catherine Rehm; Clifford Lane Journal: J Immunol Date: 2011-01-21 Impact factor: 5.422
Authors: Michael J Mugavero; Sonia Napravnik; Stephen R Cole; Joseph J Eron; Bryan Lau; Heidi M Crane; Mari M Kitahata; James H Willig; Richard D Moore; Steven G Deeks; Michael S Saag Journal: Clin Infect Dis Date: 2011-09-02 Impact factor: 9.079
Authors: Thato Iketleng; Sikhulile Moyo; Simani Gaseitsiwe; Balthazar Nyombi; Rebecca M Mitchell; Joseph Makhema; Marianna K Baum; Richard Marlink; Max Essex; Rosemary Musonda Journal: AIDS Res Hum Retroviruses Date: 2015-10-21 Impact factor: 2.205
Authors: Nongodo Firmin Kabore; Amandine Cournil; Armel Poda; Laura Ciaffi; Elizabeth Binns-Roemer; Victor David; Sabrina Eymard-Duvernay; Jacques Zoungrana; Aoua Semde; Adrien B Sawadogo; Sinata Koulla-Shiro; Charles Kouanfack; Ndeye Fatou Ngom-Gueye; Nicolas Meda; Cheryl Winkler; Sophie Limou Journal: Kidney Int Rep Date: 2021-10-16
Authors: Jonah Musa; Supriya D Mehta; Chad J Achenbach; Charlesnika T Evans; Neil Jordan; Francis A Magaji; Victor C Pam; Patrick H Daru; Olugbenga A Silas; Atiene S Sagay; Rose Anorlu; Yinan Zheng; Mamoudou Maiga; Isaac F Adewole; Robert L Murphy; Lifang Hou; Melissa A Simon Journal: Infect Agent Cancer Date: 2020-07-29 Impact factor: 2.965